Physician

Corey Ephrussi, DO

According to 2025 Medicare claims, Corey Ephrussi, DO (NPI: 1487883443) practices rheumatology in the Greenville-Anderson-Greer, SC market, with the plurality of this provider's patient population coming from Greenville, SC. This provider's primary affiliated billing organization is PIEDMONT ARTHRITIS CLINIC PA (NPI: 1124199773; TIN: 570702625) and primary practice location at 29601-3973.

Ephrussi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,035 traditional Medicare patients, billed 376,481 HCPCS/CPT codes, and received $3,635,899 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,827 prescription claims across 475 beneficiaries totaling $2,413,193 in drug costs, led by Enbrel Sureclick (Etanercept). 2016 DME data shows 26 claims. Open Payments data shows 219 records totaling $9,810. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $308 to $3,635,899. Similarly, Part D prescription costs have moved sharply higher in recent years, from $80,929 to $2,413,193. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	41	89	$308
2016	31	52	$195
2017	N/R	N/R	N/R
2018	52	122	$8,589
2019	191	8,091	$156,333
2020	218	26,700	$328,392
2021	260	32,502	$538,674
2022	274	55,110	$584,373
2023	781	194,662	$1,882,414
2024	1,035	376,481	$3,635,899

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	101	1,694	$80,929
2016	127	1,321	$76,957
2017	44	96	$9,102
2018	34	117	$110,751
2019	161	959	$927,114
2020	223	1,594	$1,053,733
2021	241	1,935	$1,558,524
2022	265	2,331	$2,862,592
2023	436	2,436	$3,032,316
2024	475	2,827	$2,413,193

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	14	$278
2016	N/R	26	$262
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	457	902	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	295	682	$86
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	342	1,241	$51
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	525	977	$8
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	216	216,000	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	116	3,304	$878,108
Humira(Cf) Pen	Adalimumab	39	1,372	$330,799
Taltz Autoinjector	Ixekizumab	30	840	$199,891
Rinvoq	Upadacitinib	18	780	$167,062
Kevzara	Sarilumab	25	868	$136,141

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	219	$9,810	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Corey Ephrussi, DO?

Tedicare shows public-source Medicare data for Corey Ephrussi, DO (NPI 1487883443), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Corey Ephrussi, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Corey Ephrussi, DO?

Corey Ephrussi, DO is linked to PIEDMONT ARTHRITIS CLINIC PA (billing NPI 1124199773) in the available physician profile data.

Does Corey Ephrussi, DO have Open Payments data?

Corey Ephrussi, DO has 219 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.